ArticleBMC medical imaging2024
Enhanced skin cancer diagnosis using optimized CNN architecture and checkpoints for automated dermatological lesion classification.
Article in BMC medical imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- The Evolving Role of Artificial Intelligence in Dermatology: A Meta-Analysis of Diagnostic Performance, Clinical Applications, and Implementation Challenges (2003-2025).Diagnostics (Basel, Switzerland) · 2026Review
- GPT Fusion: Reasoning-Based Integration of Specialized Convolutional Neural Networks for Melanoma Diagnosis.Research square · 2026Article
- Article
- CBAM-Xception: An Attention-Guided Framework for Skin Cancer Classification.Journal of imaging informatics in medicine · 2026Article
- Benchmarking MedViT and hybrid CNN-ViT architectures for multi-label thoracic disease classification.Scientific reports · 2026Article
- DermaScanAI an explainable hybrid deep learning framework for automated skin lesion classification using dual attention and metadata fusion.Scientific reports · 2026Article
- Integrating features of radiomics and CNN models for early skin cancer detection based on watershed segmentation.Discover oncology · 2026Article
- Cross-Disciplinary Mechanistic Insights in Molecular Medicine.Current issues in molecular biology · 2025Article
- Utilizing deep learning algorithms for the early identification and categorization of skin cancer.Journal, genetic engineering & biotechnology · 2025Article
- Evaluating GPT-5 for Melanoma Detection Using Dermoscopic Images.Diagnostics (Basel, Switzerland) · 2025Article
- Relation knowledge distillation 3D-ResNet-based deep learning for breast cancer molecular subtypes prediction on ultrasound videos: a multicenter study.British journal of cancer · 2025Article
- Enhanced early skin cancer detection through fusion of vision transformer and CNN features using hybrid attention of EViT-Dens169.Scientific reports · 2025Article
- Deep Learning-Based Mpox Skin Lesion Detection and Real-Time Monitoring in a Smart Healthcare System.Diagnostics (Basel, Switzerland) · 2025Article
- Deep Ensemble Learning for Multiclass Skin Lesion Classification.Bioengineering (Basel, Switzerland) · 2025Article
- Automatic melanoma detection using an optimized five-stream convolutional neural network.Scientific reports · 2025Article
- Skin cancer detection using dermoscopic images with convolutional neural network.Scientific reports · 2025Article
- An explainable hybrid deep learning framework for precise skin lesion segmentation and multi-class classification.Frontiers in medicine · 2025Article
- Enhancing Skin Cancer Diagnosis Through Fine-Tuning of Pretrained Models: A Two-Phase Transfer Learning Approach.International journal of breast cancer · 2025Article
- Multimodal Machine Learning Approach for Diagnosing Atopic Dermatitis.F1000Research · 2025Article
- Navigating the AI tide: challenges, opportunities, and future directions for early-career dermatologists.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin cancer stands as one of the foremost challenges in oncology, with its early detection being crucial for successful treatment outcomes. Traditional diagnostic methods depend on dermatologist expertise, creating a need for more reliable, automated tools. This study explores deep learning, particularly Convolutional Neural Networks (CNNs), to enhance the accuracy and efficiency of skin cancer diagnosis. Leveraging the HAM10000 dataset, a comprehensive collection of dermatoscopic images encompassing a diverse range of skin lesions, this study introduces a sophisticated CNN model tailored for the nuanced task of skin lesion classification. The model's architecture is intricately designed with multiple convolutional, pooling, and dense layers, aimed at capturing the complex visual features of skin lesions. To address the challenge of class imbalance within the dataset, an innovative data augmentation strategy is employed, ensuring a balanced representation of each lesion category during training. Furthermore, this study introduces a CNN model with optimized layer configuration and data augmentation, significantly boosting diagnostic precision in skin cancer detection. The model's learning process is optimized using the Adam optimizer, with parameters fine-tuned over 50 epochs and a batch size of 128 to enhance the model's ability to discern subtle patterns in the image data. A Model Checkpoint callback ensures the preservation of the best model iteration for future use. The proposed model demonstrates an accuracy of 97.78% with a notable precision of 97.9%, recall of 97.9%, and an F2 score of 97.8%, underscoring its potential as a robust tool in the early detection and classification of skin cancer, thereby supporting clinical decision-making and contributing to improved patient outcomes in dermatology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.